Real-time enrollment status for this moderate-to-severe atopic dermatitis clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 12:46 AM UTC
| NCT Number | NCT07690371 |
| Recruiting Status | Recruiting |
| Condition | Moderate-to-Severe Atopic Dermatitis |
| Phase | PHASE3 |
| Target Enrollment | 510 participants |
| Active Locations | 19 sites in the US |
| Sponsor | Nektar Therapeutics |
| Last Updated on CT.gov | September 14, 2026 (Sep 14, 2026) |
As of October 16, 2026: Clinical trial NCT07690371 is currently recruiting participants. This phase3 study for moderate-to-severe atopic dermatitis is actively seeking new participants at 19 locations across the United States. The study is sponsored by Nektar Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07690371 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07690371 was last updated Sep 14, 2026 (September 14, 2026). HelloStudys verifies this status automatically.